GYRE vs WY · rev $53.5M vs P/E 43, rev $3.59B
Gyre Therapeutics Inc. (GYRE) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
GYRE currently screens at market cap $589.9M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the GYRE and WY stock pages for the full models.
Not investment advice.